GlassScriptPhysician profile
Lee J Harris
NPI 1558463232
$152,407.26
in general payments reported to CMS, 2019-2025
74 companies · $6,504 in 2025
The $6,504 reported for 2025 was more than what 87% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $22K · 2021: $17K · 2022: $39K · 2023: $6,604 · 2024: $6,365 · 2025: $6,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19K · Consulting Fee: $300 · Education: $77.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,095.16 |
| Consulting Fee | $300.00 |
| Education | $77.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $64,321.94 | 2019-2025 | Mavenclad |
| Genentech USA, INC. | $24,945.86 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Genzyme Corporation | $18,223.11 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $9,261.38 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $8,950.88 | 2019-2025 | Ultomiris, Soliris |
| Banner Life Sciences, LLC | $6,539.81 | 2022-2024 | |
| Biogen, INC. | $4,276.81 | 2019-2025 | Tysabri, Vumerity, Plegridy |
| Celgene Corporation | $3,405.54 | 2021-2025 | Zeposia |
| Tg Therapeutics, INC. | $3,126.70 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $931.33 | 2019-2024 | Ajovy, Austedo Xr |
| Abbvie INC. | $881.17 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $694.29 | 2022-2025 | Purified Cortrophin Gel |
| Genentech, INC. | $635.13 | 2019-2025 | Ocrevus |
| E.R. Squibb & Sons, L.L.C. | $540.38 | 2020-2024 | Zeposia |
| Mallinckrodt Hospital Products INC. | $519.46 | 2020-2024 | Acthar |
Show all 74 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.